Entecavir - Wikipedia, the free encyclopedia
Entecavir (pronounced /ɛnˈtɛkəvɪr/) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude . Entecavir is a ...
List of antiviral drugs - Wikipedia, the free encyclopedia
Entecavir; Entry inhibitors F. Famciclovir; Fixed dose combination (antiretroviral) ... Retrieved from "http://en.wikipedia.org/wiki/List_of_antiviral_drugs "
Entecavir - Medpedia
Entecavir is an oral prescription antiviral medication used in the treatment of ... Entecavir is used to treat chronic hepatitis B. It also helps prevent the ...
CIGNA - entecavir
What is the most important information I should know about entecavir? You should not take this medication if you are allergic to entecavir, or if you also have HIV (human ...
Entecavir - Yahoo! Health
You should not take this medication if you are allergic to entecavir, or if you also have HIV (human immunodeficiency virus) that is not being treated.
"Entecavir in HIV/HBV Co-Infected Patients: Safety and Efficacy in a ...
"Entecavir in HIV/HBV Co-Infected Patients: Safety and Efficacy in a Phase II Study (ETV-038)" Reported by Jules Levin MG Pessoa reported week 24 results from the ...
Learn about Entecavir from Consumer Reports Health.
Get information on how Entecavir is used, including different forms of the medication and how they should be taken. ... Entecavir can cause serious or life ...
Entecavir - Medpedia
Entecavir is an oral prescription antiviral medication used in the treatment of chronic hepatitis B. Entecavir is in a class of drugs known as nucleoside analogue reverse ...
Entecavir for the Treatment of Chronic Hepatitis B Infection
Entecavir (ETV) is approved or has applied for approval worldwide to treat chronic ... Entecavir is a potent and selective inhibitor of the HBV DNA ...
Entecavir Active Against HIV and Selects for Antiretroviral Resistance ...
HIV and Hepatitis.com Coverage of the 14th Annual Conference on Retroviruses and Opportunistic Infections (14th CROI) February 25 - 28, 2007, Los Angeles, CA
